Skip to Main content Skip to Navigation
New interface
Journal articles

Chemical Modifications for a Next Generation of Nucleic Acid Aptamers

Abstract : In the past three decades, in vitro systematic evolution of ligands by exponential enrichment (SELEX) has yielded many aptamers for translational applications in both research and clinical settings. Despite their promise as an alternative to antibodies, the low success rate of SELEX (∼30 %) has been a major bottleneck that hampers the further development of aptamers. One hurdle is the lack of chemical diversity in nucleic acids. To address this, the aptamer chemical repertoire has been extended by introducing exotic chemical groups, which provide novel binding functionalities. This review will focus on how modified aptamers can be selected and evolved, with illustration of some successful examples. In particular, unique chemistries are exemplified. Various strategies of incorporating modified building blocks into the standard SELEX protocol are highlighted, with a comparison of the differences between pre-SELEX and post-SELEX modifications. Nucleic acid aptamers with extended functionality evolved from non-natural chemistries will open up new vistas for function and application of nucleic acids.
Complete list of metadata
Contributor : Marcel Hollenstein Connect in order to contact the contributor
Submitted on : Tuesday, November 8, 2022 - 11:06:18 AM
Last modification on : Wednesday, November 16, 2022 - 3:08:55 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2023-02-03

Please log in to resquest access to the document




Kwing Yeung Chan, Andrew Brian Kinghorn, Marcel Hollenstein, Julian Alexander Tanner. Chemical Modifications for a Next Generation of Nucleic Acid Aptamers. ChemBioChem, 2022, 23 (15), pp.e202200006. ⟨10.1002/cbic.202200006⟩. ⟨pasteur-03843493⟩



Record views